Dutch hospital data reveals hidden patterns in IBD treatment
NCT ID NCT07682038
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study looks at medical records from thousands of adults with Crohn's disease or ulcerative colitis treated in Dutch hospitals between 2018 and 2026. Researchers will analyze which treatments patients receive, how often they switch therapies, and how the disease affects other parts of the body. The goal is to understand real-world care and costs, which may help improve future treatment decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could help doctors better understand which treatments work best for different patients and improve care planning for inflammatory bowel disease.
- What could go wrong
- This is an observational study that looks at past data, so it cannot prove cause and effect. Results may not apply to patients outside the Netherlands.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLITIS, ULCERATIVE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new injection plus a pill tame ulcerative colitis?
- Can a patient registry unlock the secrets of IBD?
- Could a new pill tame inflammatory bowel disease? early safety trial begins
- Can we predict how kids with IBD will respond to treatment?
- Can switching IBD meds heal the gut when symptoms are quiet?
- Can a mediterranean diet and Time-Restricted eating tame gut inflammation?